On February 25, 2025, Microbot Medical Inc. announced a successful research collaboration with Corewell Health showing the LIBERTY Endovascular Robotic System can be used for simulated cardiovascular procedures across two remote sites, with findings to be presented at the CRT annual meeting and published in JACC.